RUA Life Sciences PLC Sustainability Reports
The company operates as a medical device group focused on the exploitation of implantable biostable polymers. It develops, patents, and manufactures long-term implantable polyurethane materials, cardiovascular devices, and vascular grafts.
Sector: Manufacturing
Country: United Kingdom
Exchange: London Stock Exchange (AIM)
LEI: 213800BMVB22PVOJ9Z28
FIGI: BBG001S9P3X7
21 reports from 2005 to 2025
